Citation: Xiang Honggang, Chen Yanmei, Zhang Jifa, Zhang Jin, Pan Dabo, Liu Bo, Ouyang Liang. Discovery of a novel sodium taurocholate cotransporting polypeptide (NTCP) inhibitor: Design, synthesis, and anti-proliferative activities[J]. Chinese Chemical Letters, ;2020, 31(6): 1422-1426. doi: 10.1016/j.cclet.2020.03.017 shu

Discovery of a novel sodium taurocholate cotransporting polypeptide (NTCP) inhibitor: Design, synthesis, and anti-proliferative activities

Xiang Honggang ^a,1 ,
Chen Yanmei ^a,1 ,
Zhang Jifa ^a,1 ,
Zhang Jin ^a ,
Pan Dabo ^b,*, ,
Liu Bo ^a,*, ,
Ouyang Liang ^a,*,

a.
State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Collaborative Innovation Center for Biotherapy, Chengdu 610041, China
b.
Institute of Traditional Chinese Medicine & Natural Products, Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China

pandabo05@163.com

liubo2400@163.com

ouyangliang@scu.edu.cn

Received Date: 17 January 2020
Revised Date: 5 March 2020
Accepted Date: 6 March 2020
Available Online: 6 March 2020

Figures(4)

Sodium taurocholate cotransporting polypeptide (NTCP) is identified as the functional receptor for HBV entry, which is responsible for upregulated HBV transcription in the HBV life cycle. Besides, NTCP is also implicated in the progression of HBV-induced hepatocellular carcinoma (HCC). Thereby, NTCP-targeting entry inhibitors are proposed to suppress HBV infection and replication in HBV-induced hepatoma therapy. Herein, we integrated in silico screening and chemical synthesis to obtain a small-molecule NTCP inhibitor B7, which exhibited moderate anti-proliferative activities against HepG2 cells and anti-HBV activity in vitro. Additionally, CETSA assay, molecular docking, and MD simulation validated that B7 could bind to NTCP. Furthermore, western blot analysis demonstrated that B7 induced apoptosis with an increased expression of Bax and caspase 3 cleaving as well as a decreasing expression of Bcl-2 in HepG2 cells. Taken together, our study identified B7 as a novel NTCP inhibitor with anti-proliferation activities which might provide a new opportunity for HCC therapy.
- Sodium taurocholate cotransporting,
- polypeptide,
- (NTCP),
- Hepatocellular carcinoma (HCC),
- HBV infection,
- NTCP inhibitor,
- Apoptosis
1. [1]
  J.D.Yang, P. Hainaut, G.J. Gores, etal., Nat. Rev. Gastro.Hepat.16(2019) 589-604. doi: 10.1038/s41575-019-0186-y
2. [2]
  H.B. El-Serag, Gastroenterology 142(2012) 1264-1273. doi: 10.1053/j.gastro.2011.12.061
3. [3]
  M.F. Yuen, D.S. Chen, G.M. Dusheiko, et al., Nat. Rev. Dis. Primers 4(2018) 18035. doi: 10.1038/nrdp.2018.35
4. [4]
  A.Jindal, A.K.Vyas, D.Kumar, G.Kumar, S.K.Sarin, Hepatol.Res.48(2018)451-458. doi: 10.1111/hepr.13049
5. [5]
  Z. Zhang, P. He, Y. Zhou, et al., Exp. Ther. Med. 16(2018) 517-522.
6. [6]
  E.J. Gane, Liver Int. 37(2017) 40-44. doi: 10.1111/liv.13304
7. [7]
  R. Perrillo, Hepatology 49(2009) S103-S111. doi: 10.1002/hep.22956
8. [8]
  G.A. Tipples, M.M. Ma, K.P. Fischer, et al., Hepatology 24(1996) 714-717.
9. [9]
  G.V. Papatheodoridis, S. Manolakopoulos, G. Dusheiko, A.J. Archimandritis, Lancet Infect. Dis. 8(2008) 167-178. doi: 10.1016/S1473-3099(07)70264-5
10. [10]
  L.Z. Ma, Z.Y. Zhang, S.P. Yin, et al., Chin. Chem. Lett. 30(2019) 1942-1946. doi: 10.1016/j.cclet.2019.07.043
11. [11]
  J.A. Zhao, H.B. Yu, S.C. Zhi, et al., Chin. Chem. Lett. 28(2017) 1539-1546. doi: 10.1016/j.cclet.2017.03.025
12. [12]
  Q. Xun, Z. Zhang, J. Luo, et al., J. Med. Chem. 61(2018) 2353-2371.
13. [13]
  B. Yu, H. Liu, X. Kong, X. Chen, C. Wu, Eur. J. Med. Chem. 163(2019) 500-511. doi: 10.1016/j.ejmech.2018.12.014
14. [14]
  J.H. Xie, Y. Lu, B.Q. Yu, J. Wu, J. Liu, Chin. Chem. Lett. 31(2020) 1173-1177. doi: 10.1016/j.cclet.2019.10.030
15. [15]
  L. Chen, W. Qiu, J. Tang, Z.F. Wang, S.Y. He, Chin. Chem. Lett. 22(2011) 413-416. doi: 10.1016/j.cclet.2010.10.036
16. [16]
  B. Hagenbuch, P.J. Meier, J. Clin. Invest. 93(1994) 1326-1331. doi: 10.1172/JCI117091
17. [17]
  H. Yan, G. Zhong, G. Xu, et al., eLife 1(2012) e00049. doi: 10.7554/eLife.00049
18. [18]
  K. Zhao, S. Liu, Y. Chen, et al., Emerg. Microbes Infec. 7(2018) 1-14.
19. [19]
  Y. Yan, L. Allweiss, D. Yang, et al., Emerg. Microbes Infec. 8(2019) 879-894. doi: 10.1080/22221751.2019.1625728
20. [20]
  Q. Gao, H. Zhu, L. Dong, et al., Cell 179(2019) 561-577. doi: 10.1016/j.cell.2019.08.052
21. [21]
  S.M. Zhao, Y.Q. Zhen, L.L. Fu, et al., Bioorg. Med. Chem. Lett. 29(2019) 126623. doi: 10.1016/j.bmcl.2019.126623
22. [22]
  J. Zhang, L.L. Fu, M. Tian, et al., Bioorg. Med. Chem. 23(2015) 976-984. doi: 10.1016/j.bmc.2015.01.020
23. [23]
  Z. Dong, S. Ekins, J.E. Polli, Mol. Pharmaceut. 10(2013) 1008-1019. doi: 10.1021/mp300453k
24. [24]
  J.M. Donkers, B. Zehnder, G.J.P. van Westen, et al., Sci. Rep. 7(2017) 15307. doi: 10.1038/s41598-017-15338-0
25. [25]
  R. Greupink, L. Dillen, M. Monshouwer, M.T. Huisman, F.G.M. Russel, Eur. J. Pharm. Sci. 44(2011) 487-496. doi: 10.1016/j.ejps.2011.09.009
26. [26]
  E.I. Lepist, H. Gillies, W. Smith, et al., PLoS One 9(2014) e87548. doi: 10.1371/journal.pone.0087548
27. [27]
  E.M. Leslie, P.B. Watkins, R.B. Kim, K.L.R. Brouwer, J. Pharmacol. Exp. Ther. 321(2007) 1170-1178. doi: 10.1124/jpet.106.119073
28. [28]
  X.J. Wang, W. Hu, T.Y. Zhang, et al., Antivir. Res. 120(2015) 140-146. doi: 10.1016/j.antiviral.2015.06.007
29. [29]
  W. He, B. Ren, F. Mao, et al., PLoS Pathog. 11(2015) e1004840. doi: 10.1371/journal.ppat.1004840
30. [30]
  X.L. Chen, H.W. Jia, Z.Y. Li, X. Xu, Chin. Chem. Lett. 30(2019) 1207-1213. doi: 10.1016/j.cclet.2019.02.033
31. [31]
  R. Jafari, H. Almqvist, H. Axelsson, et al., Nat. Protoc. 9(2014) 2100-2122. doi: 10.1038/nprot.2014.138
32. [32]
  L. Laraia, A. Friese, D. Corkery, et al., Nat. Chem. Biol. 15(2019) 710-720. doi: 10.1038/s41589-019-0307-5
1. [1]
  Zhiyu Yu , Xiang Luo , Cheng Zhang , Xin Lu , Xiaohui Li , Pan Liao , Zhongqiu Liu , Rong Zhang , Shengtao Wang , Zhiqiang Yu , Guochao Liao . Mitochondria-targeted carrier-free nanoparticles based on dihydroartemisinin against hepatocellular carcinoma. Chinese Chemical Letters, 2024, 35(10): 109519-. doi: 10.1016/j.cclet.2024.109519
2. [2]
  Yongjian Jiang , Feng Cheng , Jun Zhou , Lei Zhan , Chunmei Li , Chengzhi Huang . Regulation of cancer cell apoptosis with DNA nanocalculator. Chinese Chemical Letters, 2026, 37(1): 110071-. doi: 10.1016/j.cclet.2024.110071
3. [3]
  Mengjie Gao , Zhiqiang Cui , Yue Shen , Yikun Li , Dongxiang Zhang , Xiaoyan Gao , Yaguang Sun , Xin-Dong Jiang , Jianjun Du , Xiaohong Sun . NIR-II emissive aza-BODIPY-based nanoparticles for triggering glioblastoma apoptosis in brain. Chinese Chemical Letters, 2025, 36(5): 110098-. doi: 10.1016/j.cclet.2024.110098
4. [4]
  Yirou Wang , Futing Yang , Jun Wang , Xinghua Liao , Chun Song , Michał Nowicki , Roman Szewczyk , Na Peng . Glutathione-activated mitochondria-targeting nanosystem overcoming ferroptosis defence for dual synergism with apoptosis to enhance anti-tumor efficacy of sonodynamic therapy. Chinese Chemical Letters, 2026, 37(8): 111771-. doi: 10.1016/j.cclet.2025.111771
5. [5]
  Wenyi Mei , Lijuan Xie , Xiaodong Zhang , Cunjian Shi , Fengzhi Wang , Qiqi Fu , Zhenjiang Zhao , Honglin Li , Yufang Xu , Zhuo Chen . Design, synthesis and biological evaluation of fluorescent derivatives of ursolic acid in living cells. Chinese Chemical Letters, 2024, 35(5): 108825-. doi: 10.1016/j.cclet.2023.108825
6. [6]
  Zhi Li , Shuya Pan , Yuan Tian , Shaowei Liu , Weifeng Wei , Jinlin Wang , Tianfeng Chen , Ling Wang . Selenium nanoparticles enhance the chemotherapeutic efficacy of pemetrexed against non-small cell lung cancer. Chinese Chemical Letters, 2024, 35(12): 110018-. doi: 10.1016/j.cclet.2024.110018
7. [7]
  Chanqi Ye , Jia Zhang , Jie Shen , Ruyin Chen , Qiong Li , Peng Zhao , Dong Chen , Jian Ruan . Attractive Pickering emulsion gel loaded with oxaliplatin and lactate dehydrogenase inhibitor increases the anti-tumor effect in hepatocellular carcinoma. Chinese Chemical Letters, 2025, 36(7): 110519-. doi: 10.1016/j.cclet.2024.110519
8. [8]
  Chao Chen , Wenwen Yu , Guangen Huang , Xuelian Ren , Xiangli Chen , Yixin Li , Shenggui Liang , Mengmeng Xu , Mingyue Zheng , Yaxi Yang , He Huang , Wei Tang , Bing Zhou . Asymmetric macrocyclization enabled by Rh(Ⅲ)-catalyzed CH activation: Enantioenriched macrocyclic inhibitor of Zika virus infection. Chinese Chemical Letters, 2024, 35(11): 109574-. doi: 10.1016/j.cclet.2024.109574
9. [9]
  Liqing Chen , Zheming Zhang , Yanhong Liu , Chenfei Liu , Congcong Xiao , Liming Gong , Mingji Jin , Zhonggao Gao , Wei Huang . Systemically intravenous siRNA delivery into brain with a targeting and efficient polypeptide carrier and its evaluation on anti-glioma efficacy. Chinese Chemical Letters, 2025, 36(3): 110228-. doi: 10.1016/j.cclet.2024.110228
10. [10]
  Jinyu Guo , Yandai Lin , Shaohua He , Yueqing Chen , Fenglu Li , Renjie Ruan , Gaoxing Pan , Hexin Nan , Jibin Song , Jin Zhang . Utilizing dual-responsive iridium(Ⅲ) complex for hepatocellular carcinoma: Integrating photoacoustic imaging with chemotherapy and photodynamic therapy. Chinese Chemical Letters, 2024, 35(9): 109537-. doi: 10.1016/j.cclet.2024.109537
11. [11]
  Huiyang Chen , Zibo Li , Xiaoying Li , Chenhong Tang , Xiaoyu Liu , Minyi Nie , Ying Huang , Xiaoyu Chen , Kuncai Liu , Yilan Dai , Qiaoling Zhang , Ling Lin , Siming Zhang , Bingchen Zhang , Zhiqiang Yu . A novel mitochondria-targeted nanoprodrug amplifies oxidative stress to enhance cisplatin chemotherapy for the treatment of hepatocellular carcinoma. Chinese Chemical Letters, 2025, 36(10): 111313-. doi: 10.1016/j.cclet.2025.111313
12. [12]
  Mengmeng Miao , Yisheng Peng , Hui Liu , Hu Chen , Xu Cheng , Shangqing Chen , Kaifei Yan , Hongwei Cheng , Gang Liu . Micro-nanomaterials-engineered delivery systems for reshaping the tumor immune microenvironment in hepatocellular carcinoma. Chinese Chemical Letters, 2026, 37(5): 111390-. doi: 10.1016/j.cclet.2025.111390
13. [13]
  Lei Cao , Weidong Huang , Longlin Yin , Yu Liang , Wenhao Li , Congrui Liu , Ping Xie , Zhaonan Li , Tao Lu , Xueqin Huang , Shi Zhou , Wencheng Wu . Nanotechnology-driven innovations in transarterial chemoembolization for hepatocellular carcinoma: A focus on smart and flexible platforms. Chinese Chemical Letters, 2026, 37(8): 112643-. doi: 10.1016/j.cclet.2026.112643
14. [14]
  Hang Xiao , Hongyu Zhong , Shiqi Yang , Kunwei Li , Jing Su , Faisal Raza , Mingfeng Qiu . Folic acid-modified erythrocyte membrane enhances targeted delivery of biomimetic nanoplatforms for hepatocellular carcinoma therapy. Chinese Chemical Letters, 2026, 37(9): 111937-. doi: 10.1016/j.cclet.2025.111937
15. [15]
  Xiuyan Wan , Xincheng Qiao , Yu Zhang , Wei Pan , Na Li , Bo Tang . Logic-gated, triple-responsive DNAzyme nanoplatform for precise hepatocellular carcinoma treatment. Chinese Chemical Letters, 2026, 37(10): 112093-. doi: 10.1016/j.cclet.2025.112093
16. [16]
  Qiuye Wang , Yabing Sun , Liangxue Lai , Haijing Cui , Yonglong Ye , Ming Yang , Weihao Zhu , Bo Yuan , Quanliang Mao , Wenzhi Ren , Aiguo Wu . MMP-9-responsive probe for fluorescence-magnetic resonance dual-mode imaging of hepatocellular carcinoma models with different metastatic capacities. Chinese Chemical Letters, 2025, 36(4): 110212-. doi: 10.1016/j.cclet.2024.110212
17. [17]
  Wen-Xuan Shao , Jianyuan Wu , Gaojie Li , Yi-Hao Min , Qiu-Shuang Hu , Yu Liu , Weimin Ci , Bi-Feng Yuan . Quantitative analysis of N⁶-methyladenine at single-base resolution in mitochondrial DNA of hepatocellular carcinoma by deaminase-mediated sequencing. Chinese Chemical Letters, 2025, 36(10): 110747-. doi: 10.1016/j.cclet.2024.110747
18. [18]
  Zhendong Liu , Sainan Liu , Bin Liu , Qi Meng , Meng Yuan , Chunzheng Yang , Yulong Bian , Ping'an Ma , Jun Lin . Fe(Ⅲ)-juglone nanoscale coordination polymers for cascade chemodynamic therapy through synergistic ferroptosis and apoptosis strategy. Chinese Chemical Letters, 2024, 35(11): 109626-. doi: 10.1016/j.cclet.2024.109626
19. [19]
  Shao-Qi Guan , Chen-Hui Liu , Ya-Ping Wang , Xiao-Dong Zhang , Zhong-Min Cao , Mei Pan . Cancer cell membrane-biomimetic metallacycles for tumor microenvironment-responsive ferroptosis/apoptosis therapy with low systemic toxicity. Chinese Chemical Letters, 2026, 37(7): 111692-. doi: 10.1016/j.cclet.2025.111692
20. [20]
  Ru Ding , Chunfei Wang , E Lv , Jingjing Zhao , Xucong Zhou , Yuanyi Li , Ying Wang , Bingxue Li , Lixia Zhang , Jin Zhou . A near-infrared fluorescent probe based on Au³⁺/Pd²⁺ complexes for glutathione sensing: Applications in acute liver injury, hepatocellular carcinoma, and ferroptosis exploration. Chinese Chemical Letters, 2025, 36(11): 111497-. doi: 10.1016/j.cclet.2025.111497

Get Citation

PDF

XML

Metrics

PDF Downloads(17)
Abstract views(3223)
HTML views(252)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142